2018
Bowel management in children with spina bifida
Ambartsumyan L, Rodriguez L. Bowel management in children with spina bifida. Journal Of Pediatric Rehabilitation Medicine 2018, Preprint: 1-9. DOI: 10.3233/prm-180533.Peer-Reviewed Original ResearchQuality of lifeSpina bifidaBowel managementTreatment optionsSuccessful bowel management programTrans-anal irrigationBowel management programDevelopmental ageContinence enemaBladder dysfunctionStool consistencyBowel movementsFecal continenceOral laxativesSocial continenceConservative interventionsTreatment approachesChild's developmental ageBifidaBirth defectsContinenceVariable practiceChildrenEmotional wellbeingStepwise approachBowel management in children with spina bifida
Ambartsumyan L, Rodriguez L. Bowel management in children with spina bifida. Journal Of Pediatric Rehabilitation Medicine 2018, 11: 293-301. PMID: 30507592, DOI: 10.3233/prm-170533.Peer-Reviewed Original ResearchConceptsQuality of lifeSpina bifidaBowel managementTreatment optionsSuccessful bowel management programTrans-anal irrigationBowel management programDevelopmental ageContinence enemaBladder dysfunctionStool consistencyBowel movementsFecal continenceOral laxativesSocial continenceConservative interventionsTreatment approachesChild's developmental ageBifidaBirth defectsContinenceVariable practiceChildrenEmotional wellbeingStepwise approach
2006
Caveolin‐1 regulation of experimental colitis
Greer J, Chidlow J, Bernatchez P, Sessa W, Shukla D, Kevil C. Caveolin‐1 regulation of experimental colitis. The FASEB Journal 2006, 20: a1378-a1378. DOI: 10.1096/fasebj.20.5.a1378.Peer-Reviewed Original ResearchDisease activity indexExperimental colitisAP-CavDextran sulfate sodium (DSS) modelWild-type control miceDSS-Induced ColitisInflammatory bowel diseaseCaveolin-1Degree of inflammationWild-type miceWild-type colonAB peptideGross bleedingTransmural inflammationInduced colitisMicrovascular dysfunctionStool consistencyBowel diseaseMicrovascular functionLymphoplasmacytic infiltrateOccult bloodControl miceHistopathology scoresInflammatory responseColitis
2001
Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children
Pashankar D, Bishop W. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. The Journal Of Pediatrics 2001, 139: 428-432. PMID: 11562624, DOI: 10.1067/mpd.2001.117002.Peer-Reviewed Original ResearchConceptsChronic constipationStool frequencyStool consistencyOptimal dosePolyethylene glycol 3350Weekly stool frequencyTreatment of constipationMean effective doseFisher's exact testSignificant adverse effectsStudent's t-testFecal retentionSoft stoolDaily administrationInitial doseMean doseConstipationExact testEffective doseDoseAdverse effectsT-testChildrenTreatmentEfficacy
1990
Pathophysiology of acute diarrhea
Binder H. Pathophysiology of acute diarrhea. The American Journal Of Medicine 1990, 88: s2-s4. PMID: 2356845, DOI: 10.1016/0002-9343(90)90267-h.Peer-Reviewed Original ResearchConceptsFluid absorptionAcute infectious diarrheaMajor health problemSpecific pathogenic mechanismsElectrolyte movementStool consistencyStool frequencyIntestinal motilityStool volumeAcute diarrheaIntestinal secretionInfectious diarrheaAntidiarrheal agentsWater excretionDiarrheaPathogenic mechanismsInfectious agentsHealth problemsIntestinal tractEpithelial cellsTissue invasionLuminal osmolalitySymptomsEnterotoxin productionSigns
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply